# Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.

> **NCT07457632** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 69 (estimated)

## Conditions studied

- Diabetic Macular Edema (DME)

## Interventions

- **DIETARY_SUPPLEMENT:** Tauroursodeoxycholate (TUDCA)
- **DIETARY_SUPPLEMENT:** Traditional Chinese Medicine (mQJDHW)
- **DRUG:** placebo capsule

## Key facts

- **NCT ID:** NCT07457632
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457632, "Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07457632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*